Desidustat in the Treatment of Anemia in CKD on Dialysis Patients

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05270759` - Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Recruiting	`NCT04282616` - An Exercise Facilitator to Activate Simple Training Programs in the Dialysis Center	N/A
Completed	`NCT05241652` - Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis	N/A
Recruiting	`NCT04743947` - Vaccination Against COVID-19 in Chronic Kidney Disease

See also

Status

Clinical Trial

Phase

Recruiting

NCT05270759 - Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy

Recruiting

NCT04282616 - An Exercise Facilitator to Activate Simple Training Programs in the Dialysis Center

N/A

Completed

NCT05241652 - Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis

N/A

Recruiting

NCT04743947 - Vaccination Against COVID-19 in Chronic Kidney Disease

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04215120
Study type	Interventional
Source	Cadila Healthcare Limited
Contact
Status	Completed
Phase	Phase 3
Start date	January 4, 2020
Completion date	September 2, 2021

Desidustat in the Treatment of Anemia in CKD on Dialysis Patients — DREAM-D

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms